Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Theodora M. Ripping"'
Autor:
Theodora M. Ripping, Ellen Westhoff, Neil K. Aaronson, Mieke Van Hemelrijck, Elke Rammant, J. Alfred Witjes, Lambertus. A. Kiemeney, Katja K. H. Aben, Alina Vrieling
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-12 (2021)
Abstract Background The European Organisation for Research and Treatment of Cancer (EORTC) quality of life questionnaire for non-muscle invasive bladder cancer (QLQ-NMIBC24) has been available and applied for some years now, but has yet to undergo a
Externí odkaz:
https://doaj.org/article/ebb07d667f334bbdaeb8111287cd251f
Autor:
Janneke E W, Walraven, Theodora M, Ripping, Jorg R, Oddens, Bas W G, van Rhijn, Catharina A, Goossens-Laan, Maarten C C M, Hulshof, Lambertus A, Kiemeney, J A, Witjes, Valery E P P, Lemmens, Jacobus J M, van der Hoeven, Ingrid M E, Desar, Katja K H, Aben, Lisa M C, van Hoogstraten
Publikováno v:
BJU International, 131, 2, pp. 244-252
BlaZIB Study Group 2022, ' The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer ', BJU International . https://doi.org/10.1111/bju.15856
BJU International, 131, 244-252
BJU International. Wiley-Blackwell
BJU international. Wiley-Blackwell
BlaZIB Study Group 2022, ' The influence of multidisciplinary team meetings on treatment decisions in advanced bladder cancer ', BJU International . https://doi.org/10.1111/bju.15856
BJU International, 131, 244-252
BJU International. Wiley-Blackwell
BJU international. Wiley-Blackwell
Contains fulltext : 291201.pdf (Publisher’s version ) (Open Access) OBJECTIVES: To investigate the role of specialised genitourinary multidisciplinary team meetings (MDTMs) in decision-making and identify factors that influence the probability of r
Autor:
Diana L. Miglioretti, Mireille J.M. Broeders, Jessica Chubak, Theodora M. Ripping, Rebecca A. Hubbard
Online supplementary material providing methods details for alternative statistical approaches.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bc44672ad7169e03e7b51cac5575a44
https://doi.org/10.1158/1055-9965.22436608
https://doi.org/10.1158/1055-9965.22436608
Autor:
Diana L. Miglioretti, Mireille J.M. Broeders, Jessica Chubak, Theodora M. Ripping, Rebecca A. Hubbard
Background: This study illustrates alternative statistical methods for estimating cumulative risk of screening mammography outcomes in longitudinal studies.Methods: Data from the US Breast Cancer Surveillance Consortium (BCSC) and the Nijmegen Breast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0810b4dbfb67c43781798064bdeaf770
https://doi.org/10.1158/1055-9965.c.6515494.v1
https://doi.org/10.1158/1055-9965.c.6515494.v1
Publikováno v:
International Journal of Cancer. 140:41-49
Breast cancer screening is known to reduce breast cancer mortality. A high breast density may affect this reduction. We assessed the effect of screening on breast cancer mortality in women with dense and fatty breasts separately. Analyses were perfor
Autor:
Mireille J. M. Broeders, N.T. van Ravesteyn, K. Ten Haaf, André L. M. Verbeek, Theodora M. Ripping
Publikováno v:
Cancer Epidemiology, 42, pp. 147-53
Cancer Epidemiology, 42, 147-153. Elsevier
Cancer Epidemiology, 42, 147-53
Cancer Epidemiology, 42, 147-153. Elsevier
Cancer Epidemiology, 42, 147-53
Contains fulltext : 172530.pdf (Publisher’s version ) (Open Access) BACKGROUND: Overdiagnosis by mammographic screening is defined as the excess in breast cancer incidence in the presence of screening compared to the incidence in the absence of scr
Autor:
J.D.M. Otten, André L. M. Verbeek, Mireille J. M. Broeders, Gerard J. den Heeten, Theodora M. Ripping, Rebecca A. Hubbard
Publikováno v:
International Journal of Cancer. 138:1619-1625
Several reviews have estimated the balance of benefits and harms of mammographic screening in the general population. The balance may, however, differ between individuals with and without family history. Therefore, our aim is to assess the cumulative
Autor:
Jacques Fracheboud, N.T. van Ravesteyn, Mireille J. M. Broeders, H.J. de Koning, Theodora M. Ripping, André L. M. Verbeek
Publikováno v:
International Journal of Cancer. 137:921-929
A drawback of early detection of breast cancer through mammographic screening is the diagnosis of breast cancers that would never have become clinically detected. This phenomenon, called overdiagnosis, is ideally quantified from the breast cancer inc
Autor:
Theodora M. Ripping, Nicolien T. van Ravesteyn, Mireille J. M. Broeders, André L. M. Verbeek, Kevin ten Haaf
Publikováno v:
Journal of the National Cancer Institute, 109, 10, pp. djx060
Journal of the National Cancer Institute, 109, djx060
Journal of the National Cancer Institute, 109(10):djx060. Oxford University Press
Journal of the National Cancer Institute, 109, djx060
Journal of the National Cancer Institute, 109(10):djx060. Oxford University Press
Item does not contain fulltext Background: Overdiagnosis is the main harm of cancer screening programs but is difficult to quantify. This review aims to evaluate existing approaches to estimate the magnitude of overdiagnosis in cancer screening in or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64bb0a8bc179c2bd8e4fb6c226ae4d77
https://hdl.handle.net/2066/182648
https://hdl.handle.net/2066/182648
Autor:
Jacques Fracheboud, J.D.M. Otten, G. J. den Heeten, A.L.M. Verbeek, D van der Waal, Mireille J. M. Broeders, Theodora M. Ripping, H.J. de Koning
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 109, 2467-71
British journal of cancer, 109(9), 2467-2471. Nature Publishing Group
British Journal of Cancer, 109(9), 2467-2471. Nature Publishing Group
British Journal of Cancer, 109, 9, pp. 2467-71
British Journal of Cancer, 109, 2467-71
British journal of cancer, 109(9), 2467-2471. Nature Publishing Group
British Journal of Cancer, 109(9), 2467-2471. Nature Publishing Group
British Journal of Cancer, 109, 9, pp. 2467-71
Item does not contain fulltext Background:Trend studies investigating the impact of mammographic screening usually display age-specific mortality and incidence rates over time, resulting in an underestimate of the benefit of screening, that is, morta